With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
The observations are procedural in nature and will be responded to within the stipulated time
The partnership aims to develop novel, selective small molecules targeting TDP-43 pathology
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD
Subscribe To Our Newsletter & Stay Updated
